Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Collaboration between Uni-Bio Science Group and Swiss company Ypsomed to jointly develop 2nd generation diabetes and osteoporosis products
Media-OutReach Newswire Jean Boulle Group: European Union Approval for Tendyne Transcatheter Mitral Valve
Media-OutReach Newswire Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection